An overview on
This presentation is the property of its rightful owner.
Sponsored Links
1 / 36

An overview on health research in the Eastern Mediterranean Region PowerPoint PPT Presentation


  • 59 Views
  • Uploaded on
  • Presentation posted in: General

An overview on health research in the Eastern Mediterranean Region. June 10 th , 2014 . 34 slides. Main message. The status of health research in the key priority areas across the region is not satisfactory. There are critical deficits in: stewardship;

Download Presentation

An overview on health research in the Eastern Mediterranean Region

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


An overview on health research in the eastern mediterranean region

  • An overview on health research in the Eastern Mediterranean Region

June 10th, 2014

34 slides


Main message

Main message

  • The status of health research in the key priority areas across the region is not satisfactory.

  • There are critical deficits in:

    • stewardship;

    • translation of research into policy and practice; and

    • often research agenda.

  • These problems are mainly attributable to the weak political and subsequently financial support available to health research systems.

  • 1/23


    Publication in selected key priority areas from 2007 2012

    Publication in selected key priority areas from 2007-2012

    Quantity of research, by means of number of publications, in each priority area is not satisfactory to fill the knowledge gap.

    2/23


    An overview on health research in the eastern mediterranean region

    Composition of Systematic Review, Health Service Research and Clinical Trialsin the region, 2007-2012.

    4/23


    An overview on health research in the eastern mediterranean region

    H-index of publications (1996 -2012) by countries group

    Source: The SCImago Journal & Country Rank, the Scopus® database (Elsevier B.V.), (http://www.scimagojr.com/index.php), Nov, 2013.

    5/23


    Share of the region in the on going clinical trials

    Share of the region in the on-going clinical trials

    EMRO is even lagging behind AFRO in number of registered clinical trials.

    6/23

    Source: RøttingenJA, et al. Lancet. 2013 Oct 12;382(9900):1286-307.


    An overview on health research in the eastern mediterranean region

    Number of patent applications registered in medical technology, biotechnology and pharmaceuticals, 1997 - 2011

    Total of 5753 for

    15 years

    383.5 per year

    Source: The World Intellectual Property Organization (WIPO)

    (http://www.wipo.int/about-wipo/en/), Nov, 2013.

    7/23


    But contradictory to this discouraging state of affairs there are some opportunities still remain

    But contradictory to this discouraging state of affairs, there are some opportunities still remain.

    • The published papers seem to lack the answers to the very needs of the health priority areas by means of:

      • Quantity;

      • Relevance; and

      • Type.

  • A large proportion of the region’s research do not result in tangible outputs (product manufacture and/or decision-making).

  • 8/23


    Publication in medicine by who regions

    Publication in Medicine by WHO regions

    In 2002, the region’s share was 6111articles.

    Source: The SCImago Journal & Country Rank, the Scopus® database (Elsevier B.V.), (http://www.scimagojr.com/index.php), Nov, 2013.

    9/23


    Publication in medicine by who regions1

    Publication in Medicine by WHO regions

    More than 2 times

    • This was doubled and reached 12421 after 5 years in 2007

    Source: The SCImago Journal & Country Rank, the Scopus® database (Elsevier B.V.), (http://www.scimagojr.com/index.php), Nov, 2013.

    9/23


    Publication in medicine by who regions2

    Publication in Medicine by WHO regions

    In 2012 the number of articles has grown by almost 6 times compared to 2002.

    Almost 6 times

    Source: The SCImago Journal & Country Rank, the Scopus® database (Elsevier B.V.), (http://www.scimagojr.com/index.php), Nov, 2013.

    9/23


    Trend of publication in medicine by the emr countries

    Trendof publication in medicine by the EMR countries

    All the countries have had considerable

    Rises in their publications.

    More than 1000 publications/year

    200 -1000 publications/year


    Mission statement

    Mission statement

    • To support health care programs through sustainable health research systems and develop necessary capacities for generation ofappropriate knowledge and its utilization towards improved health.

    11/23


    An overview on health research in the eastern mediterranean region

    Financing

    • Production and utilization of research

    • To support health care programs through sustainable health research systems anddeveloping necessary capacitiesforgenerationofappropriate knowledge and its utilizationtowards improved health.

    • Resources

    Stewardship

    Source: Pang T, Sadana R, Hanney S, Bhutta ZA, Hyder AA, Simon J. Knowledge for better health: a conceptual frame- work and foundation for health research systems. Bulletin of the World Health Organization, 2003, 81(11):815–820.

    12/23


    An overview on health research in the eastern mediterranean region

    • provision of leadership to direct, coordinate, manage and review research

    Source: Pang T, Sadana R, Hanney S, Bhutta ZA, Hyder AA, Simon J. Knowledge for better health: a conceptual frame- work and foundation for health research systems. Bulletin of the World Health Organization, 2003, 81(11):815–820.

    13/23


    Financial investment in r d and health research

    Financial investment in R&D and health research

    4.6% of the world’s financial resources are produced in this region.

    Source: World Health Organization, Global Health Observatory Data Repository. http://apps.who.int/gho/data/view.main.GNI2020?lang=en (Nov 24, 2013).


    Financial i nvestment in r d and health research

    Financial investment in R&D and health research

    Data for 15 countries are based on modeling

    25%of the proportionality

    The share of research resources in the region is 1.1%.

    Source: World Health Organization, Global Health Observatory Data Repository. http://apps.who.int/gho/data/view.main.GNI2020?lang=en (Nov 24, 2013).

    Røttingen JA, et al. Lancet. 2013 Oct 12;382(9900):1286-307.

    Source: World Health Organization, Global Health Observatory Data Repository. http://apps.who.int/gho/data/view.main.GNI2020?lang=en (Nov 24, 2013).

    Røttingen JA, et al. Lancet. 2013 Oct 12;382(9900):1286-307.


    Financial i nvestment in r d and health research1

    Financial investment in R&D and health research

    The budget share of health research is 0.6% .

    14% of the proportionality

    Data for all countries are based on modeling

    Source: World Health Organization, Global Health Observatory Data Repository. http://apps.who.int/gho/data/view.main.GNI2020?lang=en (Nov 24, 2013).

    Røttingen JA, et al. Lancet. 2013 Oct 12;382(9900):1286-307.

    Source: World Health Organization, Global Health Observatory Data Repository. http://apps.who.int/gho/data/view.main.GNI2020?lang=en (Nov 24, 2013).

    Røttingen JA, et al. Lancet. 2013 Oct 12;382(9900):1286-307.


    Trend of investment on gerd gdp

    The countries’ plan in R&D investment

    in all areas –not specific to health

    Trend of investment on GERD/GDP

    1996

    2009

    0.03

    1.25

    R&D investment was 0.03% in Tunisia in 1996, but had crossed 1% in 2000.

    Expenditure on research does not exceed 0.3% of GDP, 97% of which comes from government sources.

    15/23

    Source: UNESCO Science Report, 2010.

    http://unesdoc.unesco.org/images/0018/001898/189883E.pdf.


    An overview on health research in the eastern mediterranean region

    The countries’ plan in R&D investment

    in all areas –not specific to health

    2016

    3.0

    Expenditure on research does not exceed 0.3% of GDP, 97% of which comes from government sources.

    Iranhas a Five-Year Plan to reach 3%

    15/23

    Source: UNESCO Science Report, 2010.

    http://unesdoc.unesco.org/images/0018/001898/189883E.pdf.


    Trend of investment on gerd gdp1

    The countries’ plan in R&D investment

    in all areas –not specific to health

    Trend of investment on GERD/GDP

    Expenditure on research does not exceed 0.3% of GDP, 97% of which comes from government sources.

    2011

    Qatarhad a plan in which this figure was to reach 2.8% in 2011

    2.8

    15/23

    Source: UNESCO Science Report, 2010.

    http://unesdoc.unesco.org/images/0018/001898/189883E.pdf.


    An overview on health research in the eastern mediterranean region

    The countries’ plan in R&D investment

    in all areas –not specific to health

    Expenditure on research does not exceed 0.3% of GDP, 97% of which comes from government sources.

    2012

    1.0

    Egypthad targeted 1% by 2012

    15/23

    Source: UNESCO Science Report, 2010.

    http://unesdoc.unesco.org/images/0018/001898/189883E.pdf.


    An overview on health research in the eastern mediterranean region

    The countries’ plan in R&D investment

    in all areas –not specific to health

    Expenditure on research does not exceed 0.3% of GDP, 97% of which comes from government sources.

    Many countries have shown their interest in greater investments in R&D.

    15/23

    Source: UNESCO Science Report, 2010.

    http://unesdoc.unesco.org/images/0018/001898/189883E.pdf.


    An overview on health research in the eastern mediterranean region

    Number of academic institutions in health by countries group

    Pakistan, Iran, Sudan, Egypt and Saudi Arabia have the highest numbers of institutes.

    16/23


    Number of academic institutions in health vs publication in 2012

    Number of academic institutions in health vspublication in 2012

    Pakistan and Sudan academic institutions haven’t had as many publications as expected.

    Publication in 2012

    Pakistan

    Sudan

    Number of academic institutions

    17/23


    An overview on health research in the eastern mediterranean region

    Human capital: skilled migration among countries of the region(2006 estimate by World Bank)

    The emigration rate is high in group 2 and 3 countries.

    18/23


    An overview on health research in the eastern mediterranean region

    Human capital: skilled migration among countries of the region(2006 estimate by World Bank)

    A report by the International Monetary Fund in 2009 indicated that Iran tops the list of countries losing their academic elite, with an annual loss of 150,000 to 180,000 specialists. It's equivalent to a capital loss of $50 billion.

    19/23


    Result of national health research systems nhrs assessment in the countries of the region

    Result of National Health Research Systems (NHRS) assessment in the countries of the region

    6 did not havestructure

    9 were not functional

    10 did not have all components

    • Sources: A study of national health research systems in selected countries of the WHO EMR.

    • Cairo World Health Organization’s Regional Office for the Eastern Mediterranean, 2004.

      Kennedy A, et al. East Mediterr Health J. 2008 May-Jun;14(3):502-17.

    • Ghannem H., et al. East Mediterr Health J. 2011 Mar;17(3):260-1.

    20/23


    Conclusions

    Conclusions

    • Based on the numbers of registered clinical trials and patents it can be induced that studies that lead to the manufacture of tangible products are not well-grounded in the region.

    • The few studies that have been conducted across the region indicate that research evidence does not influence decision-makings much.

    • Absence of data on health-specific research financial investment.

    • Investment in health research has remained low. However, there is a political will in several countries to increase their GERD.

    • More effective stewardship is required for the region’s health research systems.

    22/23


    An overview on health research in the eastern mediterranean region

    We need better research and research done for the right reasons

    23/23


    An overview on health research in the eastern mediterranean region

    Global Monitoring Framework

    9 global voluntary targets for 2025

    29/34


    An overview on health research in the eastern mediterranean region

    30/34


    An overview on health research in the eastern mediterranean region

    Five areas:

    • Epidemiology and burden

    • Governance for NCD

    • Prevention and reduction of risk factors

    • Health system response

      • Implementing priority interventions

      • Improving access

    • Surveillance, monitoring and evaluation

    31/34


    Ncd research priorities

    NCD research priorities

    • What are the barriers, and potential solutions of inter-sectoral collaboration on NCD?

    • What is the situation of political economy of healthy vs.unhealthy nutrition? What measures can be considered for improving situation of access and utilization of healthy foods?

    • What are the actual impacts of priority interventions on risk factor levels and global risk profile distribution?

    • What are the impacts of community health workers on NCD prevention and control?

    • What is the impact of patient education on improving adherence and strengthening the self-care?

    32/34


    Country specific

    Country specific

    • Which social groups are most adversely affected by NCD and its risk factors and determinants?(upgrading STEPS with appropriate questions and methods of analysis in this regard)

    • Are people at high risk of cardiovascular disease receiving recommended drug therapy and counseling?

    • What are the health system-related barriers to access NCD services in primary health care?

    • What are the practices of delivery of evidence-based NCD interventions at primary health care level?

    • Are evidence-based guidelines being applied to guide utilization of high-tech approaches (for example coronary revascularization)?

    33/34


    An overview on health research in the eastern mediterranean region

    34/34


  • Login